Pipenzolate bromide
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.311 |
Chemical and physical data | |
Formula | C22H28BrNO3 |
Molar mass | 434.374 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1]
Mechanism of action
[edit]Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]
References
[edit]- ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.